Byondis Announces Positive Topline Results of Pivotal Phase III TULIP® Study in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

Atriva Therapeutics Announces Changes to Management

Aptamer Group, Mologic Ink Deal to Develop Coronavirus Antigen Test

Atriva Therapeutics Announces Changes to Advisory Board